Skip to main content
OIDA Image Collection
Filters:
Reset 
A screenshot of an advertisement from the Nucynta ER website from the End-State Degenerative Joint Disease Study section as it would display on an iPad screen. It includes a bar graph that shows "Change in pain intensity as measured by mean SPID of Nucynta 50 mg and 75 mg vs. placebo (P<0.001) or 10 mg oxycodone IR vs placebo (P<0.001) at Day 5". The results are interpreted to conclude that "Nucynta 50 mg and 75 mg also demonstrated efficacy in a bunionectomy pain model". The background is white with a graph in various colors and text in red and black. Other parts of the website are visible in the background though partially obscured with a menu bar at the bottom.

Title

Nucynta ER : End-Stage Degenerative Joint Disease Study : Change in pain intensity as measured by mean SPID of NUCYNTA 50 mg and 75 mg vs placebo (P<0.001) or 10 mg oxycodone IR vs placebo (P<0.001) at Day 5 bar chart (Nucynta web based content)

Description

A screenshot of an advertisement from the Nucynta ER website from the End-State Degenerative Joint Disease Study section as it would display on an iPad screen. It includes a bar graph that shows "Change in pain intensity as measured by mean SPID of Nucynta 50 mg and 75 mg vs. placebo (P<0.001) or 10 mg oxycodone IR vs placebo (P<0.001) at Day 5". The results are interpreted to conclude that "Nucynta 50 mg and 75 mg also demonstrated efficacy in a bunionectomy pain model". The background is white with a graph in various colors and text in red and black. Other parts of the website are visible in the background though partially obscured with a menu bar at the bottom.

Drug

  • Nucynta

We encourage you to view the image in the context of its source document(s) and cite the source(s) when using these images. However, to cite just this image alone, click the “Cite This Image” button and then paste the copied text.

Information copied to your clipboard:

"Nucynta ER : End-Stage Degenerative Joint Disease Study : Change in pain intensity as measured by mean SPID of NUCYNTA 50 mg and 75 mg vs placebo (P<...